{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:49:55Z","timestamp":1791654595483,"version":"4.3.4"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"crossref","award":["9701"],"award-info":[{"award-number":["9701"]}],"id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10143-019-01134-z","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T07:44:55Z","timestamp":1561621495000},"page":"1065-1078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Pituitary adenomas and neuropsychological status: a systematic literature review"],"prefix":"10.1007","volume":"43","author":[{"given":"Marta","family":"Pertichetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Serioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Belotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Mattavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gasparotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M.","family":"Fontanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-0734","authenticated-orcid":false,"given":"Francesco","family":"Doglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"1134_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jocn.2017.01.015","volume":"42","author":"A Alsumali","year":"2017","unstructured":"Alsumali A, Cote DJ, Regestein QR, Crocker E, Alzarea A, Zaidi HA, Bi WL, Dawood HY, Broekman ML, van Zandvoort MJE, Mekary RA, Smith TR (2017) The impact of transsphenoidal surgery on neurocognitive function: a systematic review. J Clin Neurosci 42:1\u20136","journal-title":"J Clin Neurosci"},{"issue":"2","key":"1134_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1017\/S1355617710001645","volume":"17","author":"K Mussig","year":"2011","unstructured":"Mussig K et al (2011) Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients. J Int Neuropsychol Soc 17(2):369\u2013375","journal-title":"J Int Neuropsychol Soc"},{"issue":"2","key":"1134_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00019514-200304000-00005","volume":"12","author":"A Baird","year":"2003","unstructured":"Baird A, Sullivan T, Zafar S, Rock J (2003) Quality of life in patients with pituitary tumors: a preliminary study. Qual Manag Health Care 12(2):97\u2013105","journal-title":"Qual Manag Health Care"},{"issue":"6","key":"1134_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp.65.6.870","volume":"65","author":"EM Guinan","year":"1998","unstructured":"Guinan EM, Lowy C, Stanhope N, Lewis PDR, Kopelman MD (1998) Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients. J Neurol Neurosurg Psychiatry 65(6):870\u2013876","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1134_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jocn.2017.02.028","volume":"40","author":"P Hendrix","year":"2017","unstructured":"Hendrix P, Griessenauer CJ, Hans E, Simgen A, Oertel J, Karbach J (2017) Cognitive function surrounding resection of nonfunctioning pituitary adenomas with suprasellar extension: a prospective matched-control study. J Clin Neurosci 40:109\u2013114","journal-title":"J Clin Neurosci"},{"key":"1134_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clineuro.2017.03.009","volume":"156","author":"P Hendrix","year":"2017","unstructured":"Hendrix P, Hans E, Griessenauer CJ, Simgen A, Oertel J, Karbach J (2017) Neurocognitive status in patients with newly-diagnosed brain tumors in good neurological condition: the impact of tumor type, volume, and location. Clin Neurol Neurosurg 156:55\u201362","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"1134_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000012277","volume":"67","author":"CA Meyers","year":"1998","unstructured":"Meyers CA (1998) Neurobehavioral functioning of adults with pituitary disease. Psychother Psychosom 67(3):168\u2013172","journal-title":"Psychother Psychosom"},{"issue":"6","key":"1134_CR8","first-page":"255","volume":"70","author":"AM Pereira","year":"2012","unstructured":"Pereira AM et al (2012) Cognitive impairment and psychopathology in patients with pituitary diseases. Neth J Med 70(6):255\u2013260","journal-title":"Neth J Med"},{"issue":"3","key":"1134_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12020-013-0106-9","volume":"46","author":"CG Yedinak","year":"2014","unstructured":"Yedinak CG, Fleseriu M (2014) Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine 46(3):585\u2013593","journal-title":"Endocrine"},{"issue":"10","key":"1134_CR10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jocn.2011.01.027","volume":"18","author":"T Psaras","year":"2011","unstructured":"Psaras T, Milian M, Hattermann V, Gerlach C, Honegger J (2011) Executive functions recover earlier than episodic memory after microsurgical transsphenoidal resection of pituitary tumors in adult patients\u2014a longitudinal study. J Clin Neurosci 18(10):1340\u20131345","journal-title":"J Clin Neurosci"},{"issue":"6","key":"1134_CR11","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1210\/jc.2004-1375","volume":"90","author":"MO Van Aken","year":"2005","unstructured":"Van Aken MO et al (2005) Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease. J Clin Endocrinol Metab 90(6):3279\u20133286","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1134_CR12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1210\/jc.2010-2490","volume":"96","author":"J Tiemensma","year":"2011","unstructured":"Tiemensma J, Kaptein AA, Pereira AM, Smit JWA, Romijn JA, Biermasz NR (2011) Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 96(4):964\u2013971","journal-title":"J Clin Endocrinol Metab"},{"key":"1134_CR13","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. The BMJ 339:b2535","journal-title":"The BMJ"},{"issue":"12","key":"1134_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00005053-198012000-00008","volume":"168","author":"TB Whelan","year":"1980","unstructured":"Whelan TB et al (1980) Neuropsychological deficits in Cushing\u2019s syndrome. J Nerv Ment Dis 168(12):753\u2013757","journal-title":"J Nerv Ment Dis"},{"issue":"2","key":"1134_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","volume":"141","author":"MN Starkman","year":"1981","unstructured":"Starkman MN, Schteingart DE (1981) Neuropsychiatric manifestations of patients with Cushing\u2019s syndrome: relationship to cortisol and adrenocorticotropic hormone levels. Arch Intern Med 141(2):215\u2013219","journal-title":"Arch Intern Med"},{"issue":"4","key":"1134_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1530\/EJE-11-0307","volume":"165","author":"J Tiemensma","year":"2011","unstructured":"Tiemensma J, Kaptein AA, Pereira AM, Smit JWA, Romijn JA, Biermasz NR (2011) Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing\u2019s syndrome. Eur J Endocrinol 165(4):527\u2013535","journal-title":"Eur J Endocrinol"},{"key":"1134_CR17","doi-asserted-by":"crossref","unstructured":"Tooze A, Hiles CL, Sheehan JP (2012) Neurocognitive changes in pituitary adenoma patients after gamma knife radiosurgery: a preliminary study. World Neurosurgery 78(1\u20132, 122):\u2013128","DOI":"10.1016\/j.wneu.2011.09.010"},{"issue":"7","key":"1134_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1055\/s-2000-8144","volume":"108","author":"J Flitsch","year":"2000","unstructured":"Flitsch J, Spitzner S, Ludecke DK (2000) Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 108(7):480\u2013485","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"1134_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1176\/ajp.144.7.951","volume":"144","author":"JI Hudson","year":"1987","unstructured":"Hudson JI, Hudson MS, Griffing GT, Melby JC, Pope HG Jr (1987) Phenomenology and family history of affective disorder in Cushing\u2019s disease. Am J Psychiatry 144(7):951\u2013953","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1134_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00006842-198102000-00002","volume":"43","author":"MN Starkman","year":"1981","unstructured":"Starkman MN, Schteingart DE, Schork MA (1981) Depressed mood and other psychiatric manifestations of Cushing\u2019s syndrome: relationship to hormone levels. Psychosom Med 43(1):3\u201318","journal-title":"Psychosom Med"},{"issue":"3","key":"1134_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11102-011-0326-z","volume":"15","author":"C Sievers","year":"2012","unstructured":"Sievers C, S\u00e4mann PG, Pfister H, Dimopoulou C, Czisch M, Roemmler J, Schopohl J, Stalla GK, Zihl J (2012) Cognitive function in acromegaly: description and brain volumetric correlates. Pituitary 15(3):350\u2013357","journal-title":"Pituitary"},{"issue":"6","key":"1134_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s11102-016-0750-1","volume":"19","author":"S Siegel","year":"2016","unstructured":"Siegel S, Milian M, Kleist B, Psaras T, Tsiogka M, F\u00fchrer D, Koltowska-H\u00e4ggstr\u00f6m M, Honegger J, M\u00fcller O, Sure U, Menzel C, Buchfelder M, Kreitschmann-Andermahr I (2016) Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing\u2019s disease. Pituitary 19(6):590\u2013600","journal-title":"Pituitary"},{"issue":"9","key":"1134_CR23","doi-asserted-by":"publisher","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","volume":"97","author":"O Ragnarsson","year":"2012","unstructured":"Ragnarsson O, Berglund P, Eder DN, Johannsson G (2012) Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission. J Clin Endocrinol Metab 97(9):E1640\u2013E1648","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1134_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1210\/jcem-12-5-502","volume":"12","author":"AM Starr","year":"1952","unstructured":"Starr AM (1952) Personality changes in Cushing\u2019s syndrome. J Clin Endocrinol Metab 12(5):502\u2013505","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1134_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2265.1996.8690878.x","volume":"45","author":"WF Kelly","year":"1996","unstructured":"Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing\u2019s syndrome. Clin Endocrinol 45(6):715\u2013720","journal-title":"Clin Endocrinol"},{"issue":"7","key":"1134_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/qjmed\/89.7.543","volume":"89","author":"WF Kelly","year":"1996","unstructured":"Kelly WF (1996) Psychiatric aspects of Cushing\u2019s syndrome. QJM - Monthly Journal of the Association of Physicians 89(7):543\u2013551","journal-title":"QJM - Monthly Journal of the Association of Physicians"},{"issue":"4","key":"1134_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2265.1995.tb02614.x","volume":"43","author":"LD Dorn","year":"1995","unstructured":"Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kllng M, Gold PW, Chrousos GP (1995) Psychopathology in patients with endogenous Cushing\u2019s syndrome: \u2018atypical\u2019 or melancholic features. Clin Endocrinol 43(4):433\u2013442","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1134_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000364878","volume":"100","author":"M Milian","year":"2014","unstructured":"Milian M, Honegger J, Gerlach C, Hemeling X, Psaras T (2014) Similar psychopathological profiles in female and male Cushing\u2019s disease patients after treatment but differences in the pathogenesis of symptoms. Neuroendocrinology 100(1):9\u201316","journal-title":"Neuroendocrinology"},{"issue":"4","key":"1134_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1055\/s-2007-1014405","volume":"25","author":"PT Loosen","year":"1992","unstructured":"Loosen PT et al (1992) Psychiatric phenomenology in Cushing\u2019s disease. Pharmacopsychiatry 25(4):192\u2013198","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"1134_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1055\/s-0035-1569340","volume":"124","author":"S Nader","year":"2016","unstructured":"Nader S et al (2016) Health-related quality of life in patients after treatment of Cushing\u2019s disease. Exp Clin Endocrinol Diabetes 124(3):187\u2013191","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"1134_CR31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1176\/ajp.142.8.911","volume":"142","author":"RF Haskett","year":"1985","unstructured":"Haskett RF (1985) Diagnostic categorization of psychiatric disturbance in Cushing\u2019s syndrome. Am J Psychiatry 142(8):911\u2013916","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"1134_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12020-008-9112-8","volume":"34","author":"SK Mattoo","year":"2008","unstructured":"Mattoo SK, Bhansali AK, Gupta N, Grover S, Malhotra R (2008) Psychosocial morbidity in acromegaly: a study from India. Endocrine 34(1\u20133):17\u201322","journal-title":"Endocrine"},{"issue":"9","key":"1134_CR33","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1210\/jc.2010-0394","volume":"95","author":"J Leon-Carrion","year":"2010","unstructured":"Leon-Carrion J et al (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 95(9):4367\u20134379","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1134_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","volume":"20","author":"L Vilar","year":"2017","unstructured":"Vilar L, Vilar CF, Lyra R, Lyra R, Naves LA (2017) Acromegaly: clinical features at diagnosis. Pituitary 20(1):22\u201332","journal-title":"Pituitary"},{"issue":"5","key":"1134_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00005792-199409000-00001","volume":"73","author":"S Ezzat","year":"1994","unstructured":"Ezzat S et al (1994) Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) 73(5):233\u2013240","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1134_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2265.2009.03555.x","volume":"71","author":"C Sievers","year":"2009","unstructured":"Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol 71(5):691\u2013701","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1134_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1034\/j.1600-0447.2003.02383.x","volume":"107","author":"Z Korali","year":"2003","unstructured":"Korali Z, Wittchen HU, Pfister H, Hofler M, Oefelein W, Stalla GK (2003) Are patients with pituitary adenomas at an increased risk of mental disorders? Acta Psychiatr Scand 107(1):60\u201368","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"1134_CR38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1600-0404.1992.tb05500.x","volume":"86","author":"PJ Grattan-Smith","year":"1992","unstructured":"Grattan-Smith PJ, Morris JGL, Shores EA, Batchelor J, Sparks RS (1992) Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurol Scand 86(6):626\u2013631","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"1134_CR39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10072-017-2980-z","volume":"38","author":"X Wang","year":"2017","unstructured":"Wang X, Tong X, Zou Y, Tian X, Mao Z, Sun Z (2017) The impact on cognitive functions of patients with pituitary adenoma before and after surgery. Neurol Sci 38(7):1315\u20131321","journal-title":"Neurol Sci"},{"issue":"1","key":"1134_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01688639708403831","volume":"19","author":"KA Peace","year":"1997","unstructured":"Peace KA, Orme SM, Thompson AR, Padayatty S, Ellis AW, Belchetz PE (1997) Cognitive dysfunction in patients treated for pituitary tumours. J Clin Exp Neuropsychol 19(1):1\u20136","journal-title":"J Clin Exp Neuropsychol"},{"issue":"5","key":"1134_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/WNR.0000000000000757","volume":"28","author":"C Cao","year":"2017","unstructured":"Cao C et al (2017) The dysfunction of inhibition control in pituitary patients: evidence from the GoNogo event-related potential study. NeuroReport 28(5):272\u2013278","journal-title":"NeuroReport"},{"issue":"3","key":"1134_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s12020-015-0736-1","volume":"50","author":"AM Pereira","year":"2015","unstructured":"Pereira AM (2015) Neuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remission. Endocrine 50(3):523\u2013525","journal-title":"Endocrine"},{"issue":"5","key":"1134_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2265.2007.02951.x","volume":"67","author":"N Sonino","year":"2007","unstructured":"Sonino N, Ruini C, Navarrini C, Ottolini F, Sirri L, Paoletta A, Fallo F, Boscaro M, Fava GA (2007) Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol 67(5):719\u2013726","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1134_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/EJE-08-0896","volume":"160","author":"C Sievers","year":"2009","unstructured":"Sievers C, Ising M, Pfister H, Dimopoulou C, Schneider HJ, Roemmler J, Schopohl J, Stalla GK (2009) Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur J Endocrinol 160(3):367\u2013373","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1134_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","volume":"18","author":"ST Sharma","year":"2015","unstructured":"Sharma ST, Nieman LK, Feelders RA (2015) Comorbidities in Cushing\u2019s disease. Pituitary 18(2):188\u2013194","journal-title":"Pituitary"},{"issue":"1","key":"1134_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1600-0404.1993.tb04075.x","volume":"87","author":"M Mauri","year":"1993","unstructured":"Mauri M et al (1993) Memory impairment in Cushing\u2019s disease. Acta Neurol Scand 87(1):52\u201355","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"1134_CR47","first-page":"912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82(3):912\u2013919","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1134_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/archinte.1972.03650010100019","volume":"130","author":"QR Regestein","year":"1972","unstructured":"Regestein QR, Rose LI, Williams GH (1972) Psychopathology in Cushing\u2019s syndrome. Arch Intern Med 130(1):114\u2013117","journal-title":"Arch Intern Med"},{"issue":"10","key":"1134_CR49","doi-asserted-by":"publisher","first-page":"E129","DOI":"10.1210\/jc.2010-0512","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, Middelkoop HAM, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95(10):E129\u2013E141","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1134_CR50","doi-asserted-by":"publisher","first-page":"E392","DOI":"10.1210\/jc.2010-1253","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J et al (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J Clin Endocrinol Metab 95(12):E392\u2013E402","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1134_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/TEN.0b013e3181b5a738","volume":"19","author":"R Nehra","year":"2009","unstructured":"Nehra R, Grover S, Bhansali A, Khehra N (2009) Effect of corrective surgery on neurocognitive functions in endogenous Cushing syndrome. Endocrinologist 19(5):205\u2013207","journal-title":"Endocrinologist"},{"issue":"9","key":"1134_CR52","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","volume":"32","author":"MN Starkman","year":"1992","unstructured":"Starkman MN, Gebarski SS, Berent S, Schteingart DE (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome. Biol Psychiatry 32(9):756\u2013765","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1134_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/S1355617707070051","volume":"13","author":"JN Hook","year":"2007","unstructured":"Hook JN et al (2007) Patterns of cognitive change over time and relationship to age following successful treatment of Cushing\u2019s disease. J Int Neuropsychol Soc 13(1):21\u201329","journal-title":"J Int Neuropsychol Soc"},{"issue":"7","key":"1134_CR54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0033-3182(86)72657-1","volume":"27","author":"MN Starkman","year":"1986","unstructured":"Starkman MN, Schteingart DE, Schork MA (1986) Correlation of bedside cognitive and neuropsychological tests inpatients with Cushing\u2019s syndrome. Psychosomatics 27(7):508\u2013511","journal-title":"Psychosomatics"},{"issue":"6","key":"1134_CR55","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/00006842-200111000-00018","volume":"63","author":"MN Starkman","year":"2001","unstructured":"Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE (2001) Elevated cortisol levels in Cushing\u2019s disease are associated with cognitive decrements. Psychosom Med 63(6):985\u2013993","journal-title":"Psychosom Med"},{"issue":"16","key":"1134_CR56","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3760\/cma.j.issn.0366-6999.20130944","volume":"126","author":"YF Chen","year":"2013","unstructured":"Chen YF et al (2013) Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing\u2019s disease. Chin Med J 126(16):3156\u20133160","journal-title":"Chin Med J"},{"issue":"6","key":"1134_CR57","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/cen.12564","volume":"81","author":"I Crespo","year":"2014","unstructured":"Crespo I, Esther GM, Santos A, Valassi E, Yolanda VG, de Juan-Delago M, Webb SM, G\u00f3mez-Ans\u00f3n B, Resmini E (2014) Impaired decision-making and selective cortical frontal thinning in Cushing\u2019s syndrome. Clin Endocrinol 81(6):826\u2013833","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1134_CR58","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-14-0371","volume":"171","author":"A Santos","year":"2014","unstructured":"Santos A, Resmini E, Crespo I, Pires P, Vives-Gilabert Y, Granell E, Valassi E, G\u00f3mez-Anson B, Mart\u00ednez-Mombl\u00e1n MA, Matar\u00f3 M, Webb SM (2014) Small cerebellar cortex volume in patients with active Cushing\u2019s syndrome. Eur J Endocrinol 171(4):461\u2013469","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1134_CR59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EJE-13-0471","volume":"169","author":"CD Andela","year":"2013","unstructured":"Andela CD, van der Werff SJA, Pannekoek JN, van den Berg SM, Meijer OC, van Buchem MA, Rombouts SARB, van der Mast RC, Romijn JA, Tiemensma J, Biermasz NR, van der Wee NJA, Pereira AM (2013) Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing\u2019s disease: a case-control study. Eur J Endocrinol 169(6):811\u2013819","journal-title":"Eur J Endocrinol"},{"key":"1134_CR60","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.nicl.2014.01.017","volume":"4","author":"SJ van der Werff","year":"2014","unstructured":"van der Werff SJ et al (2014) Widespread reductions of white matter integrity in patients with long-term remission of Cushing\u2019s disease. Neuroimage Clin 4:659\u2013667","journal-title":"Neuroimage Clin"},{"issue":"8","key":"1134_CR61","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/npp.2015.38","volume":"40","author":"SJ van der Werff","year":"2015","unstructured":"van der Werff SJ et al (2015) Resting-state functional connectivity in patients with long-term remission of Cushing\u2019s disease. Neuropsychopharmacology 40(8):1888\u20131898","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1134_CR62","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-14-1101","volume":"173","author":"CD Andela","year":"2015","unstructured":"Andela CD et al (2015) Cushing\u2019s syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies. Eur J Endocrinol 173(1):R1\u2013R14","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1134_CR63","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1530\/EJE-15-0600","volume":"173","author":"A Santos","year":"2015","unstructured":"Santos A, Resmini E, G\u00f3mez-Ans\u00f3n B, Crespo I, Granell E, Valassi E, Pires P, Vives-Gilabert Y, Mart\u00ednez-Mombl\u00e1n MA, de Juan M, Matar\u00f3 M, Webb SM (2015) Cardiovascular risk and white matter lesions after endocrine control of Cushing\u2019s syndrome. Eur J Endocrinol 173(6):765\u2013775","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1134_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1530\/EJE-16-0779","volume":"176","author":"E Valassi","year":"2017","unstructured":"Valassi E, Crespo I, Keevil BG, Aulinas A, Urgell E, Santos A, Trainer PJ, Webb SM (2017) Affective alterations in patients with Cushing\u2019s syndrome in remission are associated with decreased BDNF and cortisone levels. Eur J Endocrinol 176(2):221\u2013231","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1134_CR65","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0006-3223(99)00203-6","volume":"46","author":"MN Starkman","year":"1999","unstructured":"Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing\u2019s disease. Biol Psychiatry 46(12):1595\u20131602","journal-title":"Biol Psychiatry"},{"issue":"2","key":"1134_CR66","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ecl.2005.01.016","volume":"34","author":"I Bourdeau","year":"2005","unstructured":"Bourdeau I, Bard C, Forget H, Boulanger Y, Cohen H, Lacroix A (2005) Cognitive function and cerebral assessment in patients who have Cushing\u2019s syndrome. Endocrinol Metab Clin N Am 34(2):357\u2013369","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"1134_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.eurpsy.2010.09.003","volume":"26","author":"T Toffanin","year":"2011","unstructured":"Toffanin T, Nifos\u00ec F, Follador H, Passamani A, Zonta F, Ferri G, Scanarini M, Amist\u00e0 P, Pigato G, Scaroni C, Mantero F, Carollo C, Perini GI (2011) Volumetric MRI analysis of hippocampal subregions in Cushing\u2019s disease: a model for glucocorticoid neural modulation. European Psychiatry 26(1):64\u201367","journal-title":"European Psychiatry"},{"issue":"5","key":"1134_CR68","first-page":"1949","volume":"87","author":"I Bourdeau","year":"2002","unstructured":"Bourdeau I et al (2002) Loss of brain volume in endogenous Cushing\u2019s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87(5):1949\u20131954","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1134_CR69","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2265.2004.02118.x","volume":"61","author":"AH Heald","year":"2004","unstructured":"Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing\u2019s disease. Clin Endocrinol 61(4):458\u2013465","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1134_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bandc.2009.02.013","volume":"71","author":"K Michaud","year":"2009","unstructured":"Michaud K, Forget H, Cohen H (2009) Chronic glucocorticoid hypersecretion in Cushing\u2019s syndrome exacerbates cognitive aging. Brain Cogn 71(1):1\u20138","journal-title":"Brain Cogn"},{"issue":"Suppl 1","key":"1134_CR71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000314317","volume":"92","author":"AM Pereira","year":"2010","unstructured":"Pereira AM, Tiemensma J, Romijn JA (2010) Neuropsychiatric disorders in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1):65\u201370","journal-title":"Neuroendocrinology"},{"issue":"6","key":"1134_CR72","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1210\/jc.2009-2032","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J et al (2010) Subtle cognitive impairments in patients with long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95(6):2699\u20132714","journal-title":"J Clin Endocrinol Metab"},{"key":"1134_CR73","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.psyneuen.2015.05.001","volume":"59","author":"JM Bas-Hoogendam","year":"2015","unstructured":"Bas-Hoogendam JM, Andela CD, van der Werff SJA, Pannekoek JN, van Steenbergen H, Meijer OC, van Buchem MA, Rombouts SARB, van der Mast RC, Biermasz NR, van der Wee NJA, Pereira AM (2015) Altered neural processing of emotional faces in remitted Cushing\u2019s disease. Psychoneuroendocrinology 59:134\u2013146","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"1134_CR74","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1017\/S1355617700611037","volume":"6","author":"H Forget","year":"2000","unstructured":"Forget H et al (2000) Cognitive decline in patients with Cushing\u2019s syndrome. J Int Neuropsychol Soc 6(1):20\u201329","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"1134_CR75","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0306-4530(01)00059-2","volume":"27","author":"H Forget","year":"2002","unstructured":"Forget H, Lacroix A, Cohen H (2002) Persistent cognitive impairment following surgical treatment of Cushing\u2019s syndrome. Psychoneuroendocrinology 27(3):367\u2013383","journal-title":"Psychoneuroendocrinology"},{"key":"1134_CR76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.psyneuen.2015.11.020","volume":"65","author":"H Forget","year":"2016","unstructured":"Forget H, Lacroix A, Bourdeau I, Cohen H (2016) Long-term cognitive effects of glucocorticoid excess in Cushing\u2019s syndrome. Psychoneuroendocrinology 65:26\u201333","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"1134_CR77","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1192\/bjp.136.2.120","volume":"136","author":"SI Cohen","year":"1980","unstructured":"Cohen SI (1980) Cushing\u2019s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136(2):120\u2013124","journal-title":"Br J Psychiatry"},{"issue":"1\u20132","key":"1134_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/BF01420501","volume":"83","author":"N Sablowski","year":"1986","unstructured":"Sablowski N, Pawlik K, L\u00fcdecke DK, Herrmann HD (1986) Aspects of personality in patients with pituitary adenomas. Acta Neurochir 83(1\u20132):8\u201311","journal-title":"Acta Neurochir"},{"issue":"4","key":"1134_CR79","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0306-4530(92)90040-E","volume":"17","author":"E Martignoni","year":"1992","unstructured":"Martignoni E, Costa A, Sinforiani E, Liuzzi A, Chiodini P, Mauri M, Bono G, Nappi G (1992) The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology 17(4):343\u2013354","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"1134_CR80","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/10547730022158672","volume":"9","author":"LD Dorn","year":"2000","unstructured":"Dorn LD, Cerrone P (2000) Cognitive function in patients with Cushing syndrome a longitudinal perspective. Clin Nurs Res 9(4):420\u2013440","journal-title":"Clin Nurs Res"},{"issue":"6","key":"1134_CR81","first-page":"735","volume":"38","author":"WY Mao","year":"2016","unstructured":"Mao WY, You H, Xing B, Zhu HJ, Feng F (2016) Advances in evaluation of cognitive impairment in patients with Cushing\u2019s disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 38(6):735\u2013738","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"5","key":"1134_CR82","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-12-0308","volume":"167","author":"MAEM Wagenmakers","year":"2012","unstructured":"Wagenmakers MAEM, Netea-Maier RT, Prins JB, Dekkers T, den Heijer M, Hermus ARMM (2012) Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur J Endocrinol 167(5):687\u2013695","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1134_CR83","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000355622","volume":"98","author":"M Milian","year":"2013","unstructured":"Milian M, Honegger J, Teufel P, Wolf A, Psaras T (2013) Tuebingen CD-25 is a sensitive tool to investigate health-related quality of life in Cushing\u2019s disease patients in the course of the disease. Neuroendocrinology 98(3):188\u2013199","journal-title":"Neuroendocrinology"},{"issue":"7","key":"1134_CR84","first-page":"e168","volume":"34","author":"T Psaras","year":"2011","unstructured":"Psaras T, Milian M, Hattermann V, Will BE, Tatagiba M, Honegger J (2011) Predictive factors for neurocognitive function and quality of life after surgical treatment for Cushing\u2019s disease and acromegaly. J Endocrinol Investig 34(7):e168\u2013e177","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"1134_CR85","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s11102-016-0756-8","volume":"19","author":"G Yordanova","year":"2016","unstructured":"Yordanova G, Martin L, Afshar F, Sabin I, Alusi G, Plowman NP, Riddoch F, Evanson J, Matson M, Grossman AB, Akker SA, Monson JP, Drake WM, Savage MO, Storr HL (2016) Long-term outcomes of children treated for Cushing\u2019s disease: a single center experience. Pituitary 19(6):612\u2013624","journal-title":"Pituitary"},{"issue":"3","key":"1134_CR86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12020-009-9182-2","volume":"35","author":"SK Mattoo","year":"2009","unstructured":"Mattoo SK, Bhansali AK, Gupta N, Grover S, Malhotra R (2009) Psychosocial morbidity in Cushing disease: a study from India. Endocrine 35(3):306\u2013311","journal-title":"Endocrine"},{"issue":"8","key":"1134_CR87","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40265-017-0735-z","volume":"77","author":"A Santos","year":"2017","unstructured":"Santos A, Resmini E, Pascual JC, Crespo I, Webb SM (2017) Psychiatric symptoms in patients with Cushing\u2019s syndrome: prevalence, diagnosis and management. Drugs 77(8):829\u2013842","journal-title":"Drugs"},{"issue":"3","key":"1134_CR88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-11-1095","volume":"167","author":"RA Feelders","year":"2012","unstructured":"Feelders RA, Pulgar SJ, Kempel A, Pereira AM (2012) The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects. Eur J Endocrinol 167(3):311\u2013326","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1134_CR89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/2230-8210.126586","volume":"18","author":"AC Ammini","year":"2014","unstructured":"Ammini AC et al (2014) Etiology and clinical profile of patients with Cushing\u2019s syndrome: a single center experience. Indian J Endocrinol Metab 18(1):99\u2013105","journal-title":"Indian J Endocrinol Metab"},{"issue":"191","key":"1134_CR90","first-page":"465","volume":"48","author":"WJ Jeffcoate","year":"1979","unstructured":"Jeffcoate WJ, Silverstone JT, Edwards CR, Besser GM (1979) Psychiatric manifestations of Cushing\u2019s syndrome: response to lowering of plasma cortisol. Q J Med 48(191):465\u2013472","journal-title":"Q J Med"},{"key":"1134_CR91","first-page":"S339","volume":"27","author":"A Bratek","year":"2015","unstructured":"Bratek A et al (2015) Psychiatric disorders associated with Cushing\u2019s syndrome. Psychiatr Danub 27:S339\u2013S343","journal-title":"Psychiatr Danub"},{"issue":"6","key":"1134_CR92","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/00005053-199606000-00006","volume":"184","author":"E Burgess","year":"1996","unstructured":"Burgess E et al (1996) Sociotropy, autonomy, stress, and depression in Cushing syndrome. J Nerv Ment Dis 184(6):362\u2013367","journal-title":"J Nerv Ment Dis"},{"issue":"5","key":"1134_CR93","first-page":"548","volume":"27","author":"SI Cohen","year":"1982","unstructured":"Cohen SI (1982) Psychiatric aspects of Cushing\u2019s syndrome. Br J Hosp Med 27(5):548","journal-title":"Br J Hosp Med"},{"issue":"2","key":"1134_CR94","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/10253890109115725","volume":"4","author":"RM Condren","year":"2001","unstructured":"Condren RM, Thakore JH (2001) Cushing\u2019s disease and melancholia. Stress 4(2):91\u2013119","journal-title":"Stress"},{"issue":"4","key":"1134_CR95","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00004583-198907000-00023","volume":"28","author":"R Frank","year":"1989","unstructured":"Frank R, Doerr HG (1989) Mania in a girl with Cushing\u2019s disease. J Am Acad Child Adolesc Psychiatry 28(4):610\u2013611","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"1134_CR96","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","volume":"42","author":"MN Starkman","year":"2013","unstructured":"Starkman MN (2013) Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinol Metab Clin N Am 42(3):477\u2013488","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"1134_CR97","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1744-859X-12-23","volume":"12","author":"A Tang","year":"2013","unstructured":"Tang A et al (2013) Psychiatric symptoms as a clinical presentation of Cushing\u2019s syndrome. Ann General Psychiatry 12(1):23","journal-title":"Ann General Psychiatry"},{"key":"1134_CR98","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnins.2015.00129","volume":"9","author":"R Pivonello","year":"2015","unstructured":"Pivonello R et al (2015) Neuropsychiatric disorders in Cushing\u2019s syndrome. Front Neurosci 9:129","journal-title":"Front Neurosci"},{"issue":"6","key":"1134_CR99","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/PRA.0000000000000113","volume":"21","author":"SA Rasmussen","year":"2015","unstructured":"Rasmussen SA et al (2015) Cushing disease presenting as primary psychiatric illness: a case report and literature review. J Psychiatr Pract 21(6):449\u2013457","journal-title":"J Psychiatr Pract"},{"issue":"2","key":"1134_CR100","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11154-009-9123-7","volume":"11","author":"N Sonino","year":"2010","unstructured":"Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing\u2019s syndrome. Rev Endocr Metab Disord 11(2):95\u2013104","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"1134_CR101","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000338408","volume":"97","author":"C Dimopoulou","year":"2013","unstructured":"Dimopoulou C et al (2013) Increased prevalence of anxiety-associated personality traits in patients with Cushing\u2019s disease: a cross-sectional study. Neuroendocrinology 97(2):139\u2013145","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1134_CR102","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11102-015-0640-y","volume":"18","author":"A Santos","year":"2015","unstructured":"Santos A et al (2015) Quality of life in Cushing\u2019s syndrome. Pituitary 18(2):195\u2013200","journal-title":"Pituitary"},{"issue":"5","key":"1134_CR103","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2165\/00023210-200115050-00003","volume":"15","author":"N Sonino","year":"2001","unstructured":"Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing\u2019s syndrome: epidemiology, pathophysiology and treatment. CNS Drugs 15(5):361\u2013373","journal-title":"CNS Drugs"},{"issue":"5\u20136","key":"1134_CR104","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000182736","volume":"39","author":"N Sonino","year":"1993","unstructured":"Sonino N et al (1993) Course of depression in Cushing\u2019s syndrome:response to treatment and comparison with graves\u2019 disease. Hormone Research in Paediatrics 39(5\u20136):202\u2013206","journal-title":"Hormone Research in Paediatrics"},{"issue":"3","key":"1134_CR105","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000012274","volume":"67","author":"N Sonino","year":"1998","unstructured":"Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing\u2019s disease. Psychother Psychosom 67(3):140\u2013146","journal-title":"Psychother Psychosom"},{"issue":"1","key":"1134_CR106","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1192\/bjp.142.1.16","volume":"142","author":"WF Kelly","year":"1983","unstructured":"Kelly WF et al (1983) Cushing\u2019s syndrome and depression\u2014a prospective study of 26 patients. Br J Psychiatry 142(1):16\u201319","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1134_CR107","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00019616-199409000-00008","volume":"4","author":"PT Loosen","year":"1994","unstructured":"Loosen PT (1994) Cushing\u2019s syndrome and depression. Endocrinologist 4(5):373\u2013382","journal-title":"Endocrinologist"},{"issue":"12","key":"1134_CR108","first-page":"460","volume":"44","author":"K Reed","year":"1983","unstructured":"Reed K, Watkins M, Dobson H (1983) Mania in Cushing\u2019s syndrome: case report. J Clin Psychiatry 44(12):460\u2013462","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"1134_CR109","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0002-9343(84)90312-7","volume":"76","author":"MF Saad","year":"1984","unstructured":"Saad MF et al (1984) Occult Cushing\u2019s disease presenting with acute psychosis. Am J Med 76(4):759\u2013766","journal-title":"Am J Med"},{"issue":"3","key":"1134_CR110","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/EJE-12-0325","volume":"167","author":"A Santos","year":"2012","unstructured":"Santos A, Resmini E, Mart\u00ednez-Mombl\u00e1n MA, Crespo I, Valassi E, Roset M, Badia X, Webb SM (2012) Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice. Eur J Endocrinol 167(3):337\u2013342","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1134_CR111","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1210\/jc.2005-1058","volume":"91","author":"JR Lindsay","year":"2006","unstructured":"Lindsay JR et al (2006) Long-term impaired quality of life in Cushing\u2019s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91(2):447\u2013453","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1134_CR112","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/EJE-15-0640","volume":"174","author":"J Tiemensma","year":"2016","unstructured":"Tiemensma J, Depaoli S, Felt JM (2016) Using subscales when scoring the Cushing\u2019s quality of life questionnaire. Eur J Endocrinol 174(1):33\u201340","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1134_CR113","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","volume":"69","author":"AA van der Klaauw","year":"2008","unstructured":"van der Klaauw AA et al (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol 69(5):775\u2013784","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1134_CR114","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11102-014-0561-1","volume":"18","author":"CD Andela","year":"2015","unstructured":"Andela CD et al (2015) Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. Pituitary 18(1):86\u2013100","journal-title":"Pituitary"},{"issue":"2","key":"1134_CR115","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11102-013-0484-2","volume":"17","author":"X Badia","year":"2014","unstructured":"Badia X et al (2014) Disease-specific quality of life evaluation and its determinants in Cushing\u2019s syndrome: what have we learnt? Pituitary 17(2):187\u2013195","journal-title":"Pituitary"},{"issue":"1","key":"1134_CR116","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1017\/cjn.2016.295","volume":"44","author":"VC Ye","year":"2017","unstructured":"Ye VC, Akagami R (2017) Perioperative quality of life in Cushing\u2019s disease. Can J Neurol Sci 44(1):69\u201377","journal-title":"Can J Neurol Sci"},{"issue":"Suppl B","key":"1134_CR117","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1096-6374(00)80013-1","volume":"10","author":"PS van Dam","year":"2000","unstructured":"van Dam PS et al (2000) Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Hormon IGF Res 10(Suppl B):S69\u2013S73","journal-title":"Growth Hormon IGF Res"},{"issue":"1\u20133","key":"1134_CR118","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.02.047","volume":"490","author":"PS Van Dam","year":"2004","unstructured":"Van Dam PS, Aleman A (2004) Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol 490(1\u20133):87\u201395","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1134_CR119","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0306-4530(03)00151-3","volume":"29","author":"H Oertel","year":"2004","unstructured":"Oertel H et al (2004) The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology 29(7):839\u2013850","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"1134_CR120","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40618-017-0722-y","volume":"40","author":"H Alibas","year":"2017","unstructured":"Alibas H et al (2017) Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy. J Endocrinol Investig 40(12):1365\u20131372","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"1134_CR121","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ghir.2014.12.003","volume":"25","author":"E Hatipoglu","year":"2015","unstructured":"Hatipoglu E et al (2015) Acromegaly and aging: a comparative cross-sectional study. Growth Hormone and IGF Research 25(1):47\u201352","journal-title":"Growth Hormone and IGF Research"},{"issue":"1","key":"1134_CR122","doi-asserted-by":"publisher","first-page":"167","DOI":"10.17219\/acem\/38156","volume":"24","author":"D Szcze\u015bniak","year":"2015","unstructured":"Szcze\u015bniak D, Jawiarczyk-Przyby\u0142owska A, Rymaszewska J (2015) The quality of life and psychological, social and cognitive functioning of patients with acromegaly. Adv Clin Exp Med 24(1):167\u2013172","journal-title":"Adv Clin Exp Med"},{"issue":"6","key":"1134_CR123","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11102-017-0831-9","volume":"20","author":"S Shan","year":"2017","unstructured":"Shan S et al (2017) Evidence of dysexecutive syndrome in patients with acromegaly. Pituitary 20(6):661\u2013667","journal-title":"Pituitary"},{"issue":"12","key":"1134_CR124","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1365-2362.2012.02721.x","volume":"42","author":"P Brummelman","year":"2012","unstructured":"Brummelman P et al (2012) Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. Eur J Clin Investig 42(12):1317\u20131324","journal-title":"Eur J Clin Investig"},{"issue":"4","key":"1134_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060041","volume":"8","author":"JF Mart\u00edn-Rodr\u00edguez","year":"2013","unstructured":"Mart\u00edn-Rodr\u00edguez JF et al (2013) Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus na\u00efve acromegaly. PLoS One 8(4):e60041","journal-title":"PLoS One"},{"issue":"3","key":"1134_CR126","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11102-008-0143-1","volume":"12","author":"C Sievers","year":"2009","unstructured":"Sievers C et al (2009) Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary 12(3):177\u2013185","journal-title":"Pituitary"},{"issue":"2","key":"1134_CR127","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12020-014-0166-5","volume":"47","author":"P Anagnostis","year":"2014","unstructured":"Anagnostis P et al (2014) Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? Endocrine 47(2):564\u2013571","journal-title":"Endocrine"},{"issue":"6","key":"1134_CR128","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1600-0447.1987.tb02848.x","volume":"75","author":"RT Abed","year":"1987","unstructured":"Abed RT et al (1987) Psychiatric morbidity in acromegaly. Acta Psychiatr Scand 75(6):635\u2013639","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"1134_CR129","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s12020-015-0634-6","volume":"50","author":"I Crespo","year":"2015","unstructured":"Crespo I et al (2015) Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly. Endocrine 50(3):756\u2013763","journal-title":"Endocrine"},{"issue":"570","key":"1134_CR130","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1192\/bjp.122.5.599","volume":"122","author":"TL Avery","year":"1973","unstructured":"Avery TL (1973) A case of acromegaly and gigantism with depression. Br J Psychiatry 122(570):599\u2013600","journal-title":"Br J Psychiatry"},{"issue":"3","key":"1134_CR131","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000012275","volume":"67","author":"K Furman","year":"1998","unstructured":"Furman K, Ezzat S (1998) Psychological features of acromegaly. Psychother Psychosom 67(3):147\u2013153","journal-title":"Psychother Psychosom"},{"issue":"1","key":"1134_CR132","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/S0790966700016402","volume":"8","author":"K Sivakumar","year":"1991","unstructured":"Sivakumar K, Williams M (1991) Psychiatric aspects of acromegaly\u2014a review and case report. Ir J Psychol Med 8(1):55\u201356","journal-title":"Ir J Psychol Med"},{"issue":"4","key":"1134_CR133","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1017\/S0790966700014270","volume":"12","author":"S Spence","year":"1995","unstructured":"Spence S (1995) The psychopathology of acromegaly. Ir J Psychol Med 12(4):142\u2013144","journal-title":"Ir J Psychol Med"},{"issue":"1","key":"1134_CR134","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1022145116901","volume":"5","author":"P Pantanetti","year":"2002","unstructured":"Pantanetti P et al (2002) Self image and quality of life in acromegaly. Pituitary 5(1):17\u201319","journal-title":"Pituitary"},{"issue":"5","key":"1134_CR135","first-page":"524","volume":"68","author":"DM Szczesniak","year":"2017","unstructured":"Szczesniak DM et al (2017) Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity? Endokrynol Pol 68(5):524\u2013532","journal-title":"Endokrynol Pol"},{"issue":"4","key":"1134_CR136","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","volume":"16","author":"S Siegel","year":"2013","unstructured":"Siegel S et al (2013) Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 16(4):507\u2013514","journal-title":"Pituitary"},{"issue":"2","key":"1134_CR137","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000448519","volume":"105","author":"C Dimopoulou","year":"2017","unstructured":"Dimopoulou C et al (2017) Body image perception in acromegaly is not associated with objective acromegalic changes but depends on depressive symptoms. Neuroendocrinology 105(2):115\u2013122","journal-title":"Neuroendocrinology"},{"issue":"6","key":"1134_CR138","first-page":"412","volume":"36","author":"O Celik","year":"2013","unstructured":"Celik O, Kadioglu P (2013) Quality of life in female patients with acromegaly. J Endocrinol Investig 36(6):412\u2013416","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"1134_CR139","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/eje.1.02214","volume":"155","author":"SM Webb","year":"2006","unstructured":"Webb SM, Badia X, Surinach NL, Spanish AcroQol Study Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155(2):269\u2013277","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1134_CR140","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11102-015-0665-2","volume":"18","author":"K Yoshida","year":"2015","unstructured":"Yoshida K, Fukuoka H, Matsumoto R, Bando H, Suda K, Nishizawa H, Iguchi G, Ogawa W, Webb SM, Takahashi Y (2015) The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL. Pituitary 18(6):876\u2013883","journal-title":"Pituitary"},{"issue":"1","key":"1134_CR141","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11102-016-0761-y","volume":"20","author":"I Crespo","year":"2017","unstructured":"Crespo I, Valassi E, Webb SM (2017) Update on quality of life in patients with acromegaly. Pituitary 20(1):185\u2013188","journal-title":"Pituitary"},{"issue":"3","key":"1134_CR142","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1530\/EJE-07-0697","volume":"158","author":"MP Matta","year":"2008","unstructured":"Matta MP et al (2008) Impaired quality of life of patients with acromegaly: control of GH\/IGF-I excess improves psychological subscale appearance. Eur J Endocrinol 158(3):305\u2013310","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1134_CR143","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","volume":"18","author":"CD Andela","year":"2015","unstructured":"Andela CD et al (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18(5):752\u2013776","journal-title":"Pituitary"},{"issue":"6","key":"1134_CR144","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1210\/jc.2004-1565","volume":"90","author":"SV Rowles","year":"2005","unstructured":"Rowles SV et al (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90(6):3337\u20133341","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1134_CR145","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000375451","volume":"103","author":"SM Webb","year":"2016","unstructured":"Webb SM, Badia X (2016) Quality of life in acromegaly. Neuroendocrinology 103(1):106\u2013111","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1134_CR146","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2265.2008.03515.x","volume":"71","author":"MF Keil","year":"2009","unstructured":"Keil MF et al (2009) Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study. Clin Endocrinol 71(3):326\u2013333","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1134_CR147","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1210\/jc.2004-0669","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"Biermasz NR et al (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89(11):5369\u20135376","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1134_CR148","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1507\/endocrj.EJ12-0424","volume":"60","author":"O Celik","year":"2013","unstructured":"Celik O et al (2013) Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center. Endocr J 60(6):753\u2013761","journal-title":"Endocr J"},{"issue":"9","key":"1134_CR149","first-page":"711","volume":"117","author":"S Ezzat","year":"1992","unstructured":"Ezzat S et al (1992) Octreotide treatment of acromegaly. A randomized, multicenter study Ann Intern Med 117(9):711\u2013718","journal-title":"A randomized, multicenter study Ann Intern Med"},{"issue":"1","key":"1134_CR150","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/eje.0.1460067","volume":"146","author":"U Feldt-Rasmussen","year":"2002","unstructured":"Feldt-Rasmussen U et al (2002) Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing\u2019s disease. Eur J Endocrinol 146(1):67\u201374","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1134_CR151","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","volume":"6","author":"MD Johnson","year":"2003","unstructured":"Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6(2):81\u201387","journal-title":"Pituitary"},{"issue":"10","key":"1134_CR152","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1210\/jc.2006-0676","volume":"91","author":"R Kauppinen-Makelin","year":"2006","unstructured":"Kauppinen-Makelin R et al (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91(10):3891\u20133896","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1134_CR153","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1530\/EJE-07-0838","volume":"158","author":"A Miller","year":"2008","unstructured":"Miller A et al (2008) Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol 158(5):587\u2013593","journal-title":"Eur J Endocrinol"},{"issue":"8 Suppl","key":"1134_CR154","first-page":"35","volume":"26","author":"P Pantanetti","year":"2003","unstructured":"Pantanetti P et al (2003) The quality of life in acromegaly. J Endocrinol Investig 26(8 Suppl):35\u201338","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"1134_CR155","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4158\/EP15855.OR","volume":"22","author":"V Papoian","year":"2016","unstructured":"Papoian V et al (2016) Patients\u2019 perception on clinical outcome and quality of life after a diagnosis of Cushing syndrome. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 22(1):51\u201367","journal-title":"Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"issue":"2","key":"1134_CR156","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","volume":"57","author":"SM Webb","year":"2002","unstructured":"Webb SM et al (2002) Acromegaly quality of life questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 57(2):251\u2013258","journal-title":"Clin Endocrinol"},{"issue":"6","key":"1134_CR157","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/cen.13331","volume":"86","author":"N Kyriakakis","year":"2017","unstructured":"Kyriakakis N et al (2017) Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: results from a 5-years prospective study. Clin Endocrinol 86(6):806\u2013815","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1134_CR158","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1530\/EJE-14-0996","volume":"172","author":"J Tiemensma","year":"2015","unstructured":"Tiemensma J et al (2015) Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test. Eur J Endocrinol 172(5):583\u2013593","journal-title":"Eur J Endocrinol"},{"key":"1134_CR159","doi-asserted-by":"crossref","unstructured":"Deijen JB et al (2005) Differential effect sizes of growth hormone replacement on quality of life, well-being and health status in growth hormone deficient patients: a meta-analysis. Health Qual Life Outcomes 3","DOI":"10.1186\/1477-7525-3-63"},{"issue":"3","key":"1134_CR160","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","volume":"67","author":"AN Paisley","year":"2007","unstructured":"Paisley AN, Rowles SV, Roberts ME, Webb SM, Badia X, Prieto L, Shalet SM, Trainer PJ (2007) Treatment of acromegaly improves quality of life, measured by AcroQol. Clin Endocrinol 67(3):358\u2013362","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1134_CR161","first-page":"326","volume":"16","author":"S Fujio","year":"2013","unstructured":"Fujio S et al (2013) Severe growth hormone deficiency is rare in surgically-cured acromegalics. Pituitary 16(3):326\u2013332","journal-title":"Pituitary"},{"issue":"1","key":"1134_CR162","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1507\/endocrj.EJ16-0182","volume":"64","author":"S Fujio","year":"2017","unstructured":"Fujio S et al (2017) Changes in quality of life in patients with acromegaly after surgical remission\u2014a prospective study using SF-36 questionnaire. Endocr J 64(1):27\u201338","journal-title":"Endocr J"},{"issue":"1","key":"1134_CR163","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF03346555","volume":"33","author":"C Sardella","year":"2010","unstructured":"Sardella C et al (2010) Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J Endocrinol Investig 33(1):20\u201325","journal-title":"J Endocrinol Investig"},{"key":"1134_CR164","first-page":"229","volume":"5","author":"VJ Geraedts","year":"2014","unstructured":"Geraedts VJ et al (2014) Health outcomes in acromegaly: depression and anxiety are promising targets for improving reduced quality of life. Front Endocrinol 5:229","journal-title":"Front Endocrinol"},{"issue":"3","key":"1134_CR165","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12020-014-0236-8","volume":"46","author":"I Crespo","year":"2014","unstructured":"Crespo I, Webb SM (2014) Perception of health and cognitive dysfunction in acromegaly patients. Endocrine 46(3):365\u2013367","journal-title":"Endocrine"},{"issue":"SUPPL. 1","key":"1134_CR166","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1007\/s11102-013-0519-8","volume":"17","author":"M Guitelman","year":"2014","unstructured":"Guitelman M et al (2014) Patient-focussed outcomes in acromegaly. Pituitary 17(SUPPL. 1):S18\u2013S23","journal-title":"Pituitary"},{"issue":"8","key":"1134_CR167","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1212\/WNL.0000000000002252","volume":"86","author":"A Bala","year":"2016","unstructured":"Bala A, \u0141ojek E, Marchel A (2016) Cognitive functioning of patients with a PRL-secreting pituitary adenoma. Neurology 86(8):731\u2013734","journal-title":"Neurology"},{"issue":"3","key":"1134_CR168","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000012273","volume":"67","author":"LG Sobrinho","year":"1998","unstructured":"Sobrinho LG (1998) Emotional aspects of hyperprolactinemia. Psychother Psychosom 67(3):133\u2013139","journal-title":"Psychother Psychosom"},{"issue":"3","key":"1134_CR169","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000335996","volume":"96","author":"AP Athanasoulia","year":"2012","unstructured":"Athanasoulia AP et al (2012) Distinct dopaminergic personality patterns in patients with prolactinomas: a comparison with nonfunctioning pituitary adenoma patients and age-and gender-matched controls. Neuroendocrinology 96(3):204\u2013211","journal-title":"Neuroendocrinology"},{"issue":"5","key":"1134_CR170","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0033-3182(10)70718-0","volume":"51","author":"S Ali","year":"2010","unstructured":"Ali S, Miller KK, Freudenreich O (2010) Management of psychosis associated with a prolactinoma: case report and review of the literature. Psychosomatics 51(5):370\u2013376","journal-title":"Psychosomatics"},{"issue":"1","key":"1134_CR171","doi-asserted-by":"publisher","first-page":"125.e1","DOI":"10.1016\/j.genhosppsych.2013.01.010","volume":"36","author":"WT Liao","year":"2014","unstructured":"Liao WT, Bai YM (2014) Major depressive disorder induced by prolactinoma\u2014a case report. Gen Hosp Psychiatry 36(1):125.e1\u2013125.e2","journal-title":"Gen Hosp Psychiatry"},{"issue":"3\u20134","key":"1134_CR172","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/00207458708987147","volume":"37","author":"R Sandyk","year":"1987","unstructured":"Sandyk R, Bergsneider M, Iacono RP (1987) Acute psychosis in a woman with a prolactinoma. Int J Neurosci 37(3\u20134):187\u2013190","journal-title":"Int J Neurosci"},{"issue":"3","key":"1134_CR173","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2265.1997.2701073.x","volume":"47","author":"A Reavley","year":"1997","unstructured":"Reavley A et al (1997) Psychological distress in patients with hyperprolactinaemia. Clin Endocrinol 47(3):343\u2013348","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1134_CR174","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1530\/EJE-07-0259","volume":"157","author":"M Kars","year":"2007","unstructured":"Kars M et al (2007) Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol 157(2):133\u2013139","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1134_CR175","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11102-008-0091-9","volume":"11","author":"E Cesar de Oliveira Naliato","year":"2008","unstructured":"Cesar de Oliveira Naliato E et al (2008) Quality of life in women with microprolactinoma treated with dopamine agonists. Pituitary 11(3):247\u2013254","journal-title":"Pituitary"},{"key":"1134_CR176","doi-asserted-by":"crossref","first-page":"675310","DOI":"10.5402\/2012\/675310","volume":"2012","author":"A Raappana","year":"2012","unstructured":"Raappana A et al (2012) Long-term health-related quality of life of surgically treated pituitary adenoma patients: a descriptive study. ISRN Endocrinol 2012:675310","journal-title":"ISRN Endocrinol"},{"issue":"4","key":"1134_CR177","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.2010.03947.x","volume":"74","author":"P Brummelman","year":"2011","unstructured":"Brummelman P et al (2011) Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol 74(4):481\u2013487","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1134_CR178","first-page":"41","volume":"27","author":"HA Chang","year":"2007","unstructured":"Chang HA et al (2007) Mood disorder due to nonfunctioning pituitary adenoma with a major depressive-like episode in a postmenopausal woman. J Med Sci 27(1):41\u201345","journal-title":"J Med Sci"},{"issue":"2","key":"1134_CR179","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/EJE-16-0875","volume":"176","author":"M Elbornsson","year":"2017","unstructured":"Elbornsson M et al (2017) Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol 176(2):99\u2013109","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1134_CR180","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/BF03350340","volume":"33","author":"NP Maric","year":"2010","unstructured":"Maric NP et al (2010) Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy. J Endocrinol Investig 33(11):770\u2013775","journal-title":"J Endocrinol Investig"},{"issue":"9 Suppl","key":"1134_CR181","first-page":"52","volume":"31","author":"SM Webb","year":"2008","unstructured":"Webb SM (2008) Measurements of quality of life in patients with growth hormone deficiency. J Endocrinol Investig 31(9 Suppl):52\u201355","journal-title":"J Endocrinol Investig"},{"issue":"10","key":"1134_CR182","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00701-012-1473-3","volume":"154","author":"E Tanemura","year":"2012","unstructured":"Tanemura E, Nagatani T, Aimi Y, Kishida Y, Takeuchi K, Wakabayashi T (2012) Quality of life in nonfunctioning pituitary macroadenoma patients before and after surgical treatment. Acta Neurochir 154(10):1895\u20131902","journal-title":"Acta Neurochir"},{"issue":"5","key":"1134_CR183","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1210\/jc.2010-2742","volume":"96","author":"NR Biermasz","year":"2011","unstructured":"Biermasz NR et al (2011) Patients previously treated for nonfunctioning pituitary macroadenomas have disturbed sleep characteristics, circadian movement rhythm, and subjective sleep quality. J Clin Endocrinol Metab 96(5):1524\u20131532","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1134_CR184","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.1365-2265.1997.1400957.x","volume":"46","author":"RCL Page","year":"1997","unstructured":"Page RCL et al (1997) An account of the quality of life of patients after treatment for non- functioning pituitary tumours. Clin Endocrinol 46(4):401\u2013406","journal-title":"Clin Endocrinol"},{"issue":"9","key":"1134_CR185","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00701-013-1809-7","volume":"155","author":"M Milian","year":"2013","unstructured":"Milian M et al (2013) Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors\u2014a longitudinal study of 106 patients. Acta Neurochir 155(9):1637\u20131645 discussion 1645","journal-title":"Acta Neurochir"},{"issue":"3","key":"1134_CR186","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2265.1998.00543.x","volume":"49","author":"KA Peace","year":"1998","unstructured":"Peace KA et al (1998) Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin Endocrinol 49(3):391\u2013396","journal-title":"Clin Endocrinol"},{"issue":"9","key":"1134_CR187","first-page":"3184","volume":"83","author":"HB Baum","year":"1998","unstructured":"Baum HB et al (1998) Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 83(9):3184\u20133189","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1134_CR188","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejrad.2014.11.033","volume":"84","author":"P Brummelman","year":"2015","unstructured":"Brummelman P et al (2015) Cognition and brain abnormalities on MRI in pituitary patients. Eur J Radiol 84(2):295\u2013300","journal-title":"Eur J Radiol"},{"issue":"4","key":"1134_CR189","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.clon.2004.01.012","volume":"16","author":"R Noad","year":"2004","unstructured":"Noad R et al (2004) Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clin Oncol (R Coll Radiol) 16(4):233\u2013237","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"1134_CR190","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5812\/kowsar.1726913X.2597","volume":"9","author":"C Petry","year":"2011","unstructured":"Petry C et al (2011) Assessment of cognitive function, mood, and quality of life in hypopituitary patients after pituitary adenomectomy with or without radiotherapy. International Journal of Endocrinology and Metabolism 9(2):306\u2013310","journal-title":"International Journal of Endocrinology and Metabolism"},{"issue":"4","key":"1134_CR191","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2007.01.017","volume":"68","author":"AP van Beek","year":"2007","unstructured":"van Beek AP et al (2007) Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma. Int J Radiat Oncol Biol Phys 68(4):986\u2013991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1134_CR192","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2265.2007.03169.x","volume":"69","author":"AA Van Der Klaauw","year":"2008","unstructured":"Van Der Klaauw AA et al (2008) Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol 69(1):123\u2013128","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1134_CR193","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/A:1009926122406","volume":"2","author":"IM Jackson","year":"1999","unstructured":"Jackson IM, Noren G (1999) Role of gamma knife radiosurgery in acromegaly. Pituitary 2(1):71\u201377","journal-title":"Pituitary"},{"issue":"1","key":"1134_CR194","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0889-8529(05)70060-8","volume":"28","author":"IM Jackson","year":"1999","unstructured":"Jackson IM, Noren G (1999) Role of gamma knife therapy in the management of pituitary tumors. Endocrinol Metab Clin N Am 28(1):133\u2013142","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"1134_CR195","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.59.1.40","volume":"59","author":"CL Armstrong","year":"2002","unstructured":"Armstrong CL et al (2002) Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 59(1):40\u201348","journal-title":"Neurology"},{"issue":"1\u20132","key":"1134_CR196","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.wneu.2011.12.060","volume":"78","author":"J Murovic","year":"2012","unstructured":"Murovic J, Chang S (2012) Neurocognitive changes in pituitary adenoma patients after fractionated external beam radiotherapy versus gamma knife radiosurgery. World Neurosurgery 78(1\u20132):53\u201357","journal-title":"World Neurosurgery"},{"issue":"6","key":"1134_CR197","first-page":"375","volume":"66","author":"IT Lee","year":"2003","unstructured":"Lee IT, Lin SY, Sheul WH (2003) Mood disorder and secondary adrenal insufficiency after pituitary tumor operation and radiotherapy. J Chin Med Assoc 66(6):375\u2013378","journal-title":"J Chin Med Assoc"},{"issue":"3","key":"1134_CR198","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1365-2265.2006.02462.x","volume":"64","author":"N Sonino","year":"2006","unstructured":"Sonino N et al (2006) Personality characteristics and quality of life in patients treated for Cushing\u2019s syndrome. Clin Endocrinol 64(3):314\u2013318","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1134_CR199","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11102-012-0425-5","volume":"16","author":"N Alcalar","year":"2013","unstructured":"Alcalar N et al (2013) Evaluation of depression, quality of life and body image in patients with Cushing\u2019s disease. Pituitary 16(3):333\u2013340","journal-title":"Pituitary"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-019-01134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-019-01134-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-019-01134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T08:41:45Z","timestamp":1721464905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-019-01134-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,27]]},"references-count":199,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1007\/s10143-019-01134-z","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,27]]},"assertion":[{"value":"28 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}